Literature DB >> 8557987

Generation of primary tumor-specific CTL in vitro to immunogenic and poorly immunogenic mouse tumors.

B Liu1, E R Podack, J P Allison, T R Malek.   

Abstract

This study investigated the generation of primary tumor-specific CTL activity in vitro to several mouse tumors. We report that the development of optimal primary tumor-specific CTL to the P815 mastocytoma, the EL4 thymoma, and the Lewis lung carcinoma is dependent on tumor Ags, on enhancement of T cell costimulation by B7.1, and on exogenous T helper activity in the form of IL-2 and IL-4. A relatively low concentration of IL-2 and IL-4 was required to limit the induction of lymphokine-activated killer cells. In the case of P815, the CTL were directed toward molecularly defined tumor rejection Ags. These primary cultures yielded long term T cell lines that were heterogeneous in fine tumor Ag specificity and in cytokine production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8557987

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

Review 1.  Lung cancer immunotherapy.

Authors:  Luis E Raez; Steven Fein; Eckhard R Podack
Journal:  Clin Med Res       Date:  2005-11

2.  Keratinocyte growth factor (KGF) enhances postnatal T-cell development via enhancements in proliferation and function of thymic epithelial cells.

Authors:  Simona W Rossi; Lukas T Jeker; Tomoo Ueno; Sachiyo Kuse; Marcel P Keller; Saulius Zuklys; Andrei V Gudkov; Yousuke Takahama; Werner Krenger; Bruce R Blazar; Georg A Holländer
Journal:  Blood       Date:  2007-01-09       Impact factor: 22.113

Review 3.  Anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) immunotherapy for the treatment of prostate cancer.

Authors:  R Houston Thompson; James P Allison; Eugene D Kwon
Journal:  Urol Oncol       Date:  2006 Sep-Oct       Impact factor: 3.498

4.  A synergistic antitumor effect of interleukin-2 addition with CD80 immunogene therapy for peritoneal metastasis of gastric carcinoma.

Authors:  Kinshi Kosaka; Masakazu Yashiro; Yoji Sakate; Kosei Hirakawa
Journal:  Dig Dis Sci       Date:  2007-04-03       Impact factor: 3.199

5.  Interleukin-7 receptor alpha is essential for the development of gamma delta + T cells, but not natural killer cells.

Authors:  Y W He; T R Malek
Journal:  J Exp Med       Date:  1996-07-01       Impact factor: 14.307

6.  Therapeutic limitations in tumor-specific CD8+ memory T cell engraftment.

Authors:  Oliver F Bathe; Nava Dalyot-Herman; Thomas R Malek
Journal:  BMC Cancer       Date:  2003-07-28       Impact factor: 4.430

Review 7.  Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response.

Authors:  John Reiser; Arnob Banerjee
Journal:  J Immunol Res       Date:  2016-05-22       Impact factor: 4.818

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.